NICE proposes to withdraw Alzheimer's drugs from NHSBMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7490.495-a (Published 03 March 2005) Cite this as: BMJ 2005;330:495
- Zosia Kmietowicz
The drugs donepezil, rivastigmine, galantamine, and memantine should no longer be prescribed on the NHS to treat Alzheimer's disease, says new draft guidance from the National Institute for Clinical Excellence (NICE).
NICE, the NHS prescribing watchdog for England and Wales, has retracted its previous guidance“issued in 2001 and which said that these drugs should be prescribed for Alzheimer's disease—after reviewing the latest evidence on efficacy and cost effectiveness. Patients currently receiving any of the drugs, however, can continue to do so. Memantine will be available only as part of …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial